Skip to main content
Clinical Trials/IRCT20210718051920N2
IRCT20210718051920N2
Recruiting
Phase 3

Evaluation of the efficacy of nasal spray formulation containing tea tree oil in the treatment of seasonal allergic rhinitis: a randomized double-blind placebo-controlled clinical trial

Kerman University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Kerman University of Medical Sciences
Enrollment
70
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Seasonal allergic rhinitis confirmed by skin prick test

Exclusion Criteria

  • Structural disorders of the nose such as nasal polyps, nasal deviation and other structural disorders
  • Chronic obstructive pulmonary disease (COPD)
  • Rhinosinusitis
  • Chronic diseases such as kidney failure, liver failure, hypertension, diabetes, ischemic heart disease, Malignancy, and systemic inflammatory diseases
  • Respiratory infections during the previous 8 weeks
  • Use of oral corticosteroids during the previous week
  • Patients who are receiving immunotherapy or have a history of immunotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials